Browsing by Author Karapetis, Christos (Chris)

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)Citation
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2018Adjuvant therapy for resected colon cancer 2017, including the IDEA analysisPavlakis, Nick; Tang, Monica; Arnold, Dirk; Burge, Matthew; Gibbs, Peter; Haller, Daniel; Karapetis, Christos (Chris); Peeters, Marc; Price, Timothy; Roy, Amitesh; Segelov, Eva; Shapiro, Jeremy; Tebbutt, Niall; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreAdjuvant therapy for resected colon cancer 2017, including the IDEA analysis, Expert Review of Anticancer Therapy, vol.18, 4, 2018,pp 339-349
2004Audit Of Postoperative Chemoradiotherapy As Adjuvant Therapy For Resected Gastroesophageal Adenocarcinoma: An Australian Multicentre Experience.Yip, Desmond; Burmeister, Bryan; Carroll, Susan; Chao, Michael W.; Gibbs, Peter; Goldstein, David; Hughes, Brett G; Karapetis, Christos (Chris); MedicineAudit Of Postoperative Chemoradiotherapy As Adjuvant Therapy For Resected Gastroesophageal Adenocarcinoma: An Australian Multicentre Experience., ANZ Journal of Surgery, vol.74,(11),2004,pp 951-956
2007Cetuximab for the Treatment of Colorectal CancerSimes, Robert John; Zalcberg, John; Au, Heather Jane; Berry, Scott R.; et, al; Jonker, Derek J.; Karapetis, Christos (Chris); Krahn, Marianne; O’Callaghan, Chris J.; Price, Timothy; Tebbutt, Niall C; Tu, Dongsheng; van Hazel, Guy; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreCetuximab for the Treatment of Colorectal Cancer, New England Journal of Medicine, vol.357,(20),2007,pp 2040-2048
2014Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancerSimes, Robert John; et al, Various; Harbison, C; Jonker, Derek J.; Karapetis, Christos (Chris); Langer, C; Malone, DP; O’Callaghan, C; Price, Timothy; Shapiro, J; Tebbutt, Niall; Tu, Dongsheng; School of Public Health: NH&MRC Clinical Trials CentreEpiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer, British Journal of Cancer, vol.110, 3, 2014,pp 648-655
2013Phase III Randomized, Placebo-Controlled Study of Cetuximab Plus Brivanib Alaninate Versus Cetuximab Plus Placebo in PatientsWith Metastatic, Chemotherapy-Refractory, Wild-TypeK-RASColorectal Carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 TrialSimes, Robert John; Zalcberg, John; Charpentier, Danielle; Couture, Felix; et al, Various; Jonker, Derek J.; Karapetis, Christos (Chris); Moore, Malcolm; Nott, Louise M; Price, Timothy; Shapiro, Jeremy; Siddiqui, Jehan; Siu, Lillian L; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentrePhase III Randomized, Placebo-Controlled Study of Cetuximab Plus Brivanib Alaninate Versus Cetuximab Plus Placebo in PatientsWith Metastatic, Chemotherapy-Refractory, Wild-TypeK-RASColorectal Carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 Trial, Journal of Clinical Oncology, vol.31, 19, 2013,pp 2477-2484
2016Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM StudyGebski, Val; Khasraw, Mustafa; Pavlakis, Nick; Robledo, Kristy; Simes, Robert John; Thavaneswaran, Subotheni; Wilson, Kate; Chantrill, Lorraine A; Desai, Jayesh; Elez, Elena; et al, Various; Karapetis, Christos (Chris); Lunke, Sebastian; Nott, Louise M; Segelov, Eva; Underhill, Craig; Waring, Paul; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; School of Molecular Bioscience (SMB)Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study, Journal of Clinical Oncology, vol.34, 19, 2016,pp 2258-2264